Publications by authors named "Martin Canas"

Claim this Profile
U
Use of nervous system medications with fetal risk before and during pregnancy in an Argentine social security system.
Cecilia Anahi Alvarez Rotondo, Gustavo H Marín, Lupe Marín, Solange Mollo, Martín A Urtasun

Rev Colomb Obstet Ginecol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market].
Mariana Caffaratti, Martín Cañás, Daniel Eduardo Domosbian, Emiliano Giraudo, Ana María González

Rev Fac Cien Med Univ Nac Cordoba· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prescription patterns of psychotropic drugs in inpatient and in community outpatient care at the neuropsychiatric hospital “Dr. Alejandro Korn”, La Plata, Argentina. Cross-sectional study].
Pedro Damián Gargoloff, Martín A Urtasun, Raúl Riveros, Verónica Ruiz, Martín Cañás

Vertex· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meniscal Lesions in Multi-Ligament Knee Injuries.
David Figueroa, María Loreto Figueroa, Martin Cañas, Alexandra Feuereisen, Francisco Figueroa

Indian J Orthop· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy.
Fernanda Lacerda da Silva Machado, Martín Cañás, Martín A Urtasun, Gustavo H Marín, Flavia Caixeta Albuquerque

Ther Innov Regul Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Concordance between essential medicines lists and diabetes guidelines in Latin America and the CaribbeanConcordância entre as listas de medicamentos essenciais e diretrizes para diabetes na América Latina e no Caribe].
Martín Alejandro Urtasun, Cristian Dorati, Martín Cañás, María Silvina Bruzzone, Gustavo H Marín

Rev Panam Salud Publica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison.
Fernanda Lacerda da Silva Machado, Martín Cañás, Svetlana V Doubova, Martín A Urtasun, Gustavo H Marín

Regul Toxicol Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Economic impact of high-price/cost medicines on social security in Argentina. The case of the Institute for the Armed and Security Forces].
Gustavo H Marin, Martín Cañas, Gina Marin, Lupe Marin, Daniel Nucher

Medicina (B Aires)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Medicines withdrawn in other countries due to safety concerns: should they continue to be available in the Argentine pharmaceutical market?].
Héctor Buschiazzo, Cristian Dorati, Nasim Iusef Venturini, Martín Cañas, Martín Alejandro Urtasun

Rev Fac Cien Med Univ Nac Cordoba· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Use of benzodiazepines and related drugs in social security for older adults in Argentina].
Martín A Urtasun, María Noble, Martín Cañás, Julián Bustin, Alejandro J Regueiro

Medicina (B Aires)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study.
Luciane C Lopes, Maribel Salas, Claudia Garcia Serpa Osorio-de-Castro, Lisiane Freitas Leal, Svetlana V Doubova

Pharmacoepidemiol Drug Saf· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential negative impact of reputed regulators' decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis.
Carlos E Durán, Martín Cañás, Martín Urtasun, Monique Elseviers, Robert Vander Stichele

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?].
Gustavo Marin, Julieta Del Mauro, Lupe Marin, Martin A Urtasun, Gina Marin

Salud Colect· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data transparency for building a stronger healthcare system: A case study from Argentinean administrative drug utilization data sources.
Martín Cañás, Gustavo H Marín, Martín A Urtasun, Lisiane Freitas Leal, Maribel Salas

Salud Colect· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries.
Carlos E Durán, Martín Cañás, Martín A Urtasun, Monique Elseviers, Tatiana Andia

Rev Panam Salud Publica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reduction of social coverage for symptomatic slow-acting drugs for osteoarthritis: a disinvestment initiative in Argentina, 2015-2017].
Martín A Urtasun, María Noble, Martín Cañás, Julián Bustin, Ricardo C Mastai

Salud Colect· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is happening with not recommended drugs for dementia in Argentina? Prescription patterns and direct costs analysis.
Julian Bustin, Galeno Rojas, Santiago O'Neill, Diego Sarasola, Fabian Triskier

Int J Geriatr Psychiatry· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Psychotropic drugs prescription to elderly people in the national institute of social services for retirees and pensioners of argentina (PAMI)].
Julián Bustin, Fabián Triskier, Javier Arakaki, Jorge Pérez Blanco, Martín Urtasun

Vertex· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMA and FDA decisions based on flawed evidence to approve new cancer drugs negatively affect Latin American patients.
Carlos E Durán, Martín Cañás, Thierry Chistiaens

BMJ· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cardiovascular risk of non-steroidal anti-inflammatory drugs].
Guillermo R Prozzi, Martín Cañás, Martín A Urtasun, Héctor O Buschiazzo, Cristian M Dorati

Medicina (B Aires)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic value and price of the new pharmaceuticals commercialized in Argentina: Are they worth what they cost?
Martín Cañás, Héctor Omar Buschiazzo, Martín Alejandro Urtasun

Salud Colect· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevalence of cognitive impairment in a high social risk population older then 60 years from Neuquén capital, Argentina].
Martín Regueiro, Cecilia Homar, Martín Cañás, Virginia Tosello

Vertex· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs".
Martin A Urtasun, Guillermo R Prozzi, Gustavo H Marín, Hector O Buschiazzo, Martín Cañás

Am J Cardiovasc Drugs· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Salt in the diet: opinions, guides and evidence].
Martín A Urtasun, Martín Cañás

Salud Colect· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Use of medication in elderly people don't institutionalized].
Martín Regueiro, Nicolás Mendy, Martín Cañás, Hugo Osvaldo Farina, Pablo Nagel

Rev Peru Med Exp Salud Publica· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis